Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -62.84% is 11% below its 5-year average of -56.44%, around the middle of its 5-year range (-79.83%–-38.31%).
0.88% below its 12-month average of -62.29%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -15.96%.
RETURN ON ASSETS (ROA)
-62.84%
RETURN ON ASSETS (ROA) AVG TTM
-62.29%
RETURN ON ASSETS (ROA) AVG 3Y
-62.24%
RETURN ON ASSETS (ROA) AVG 5Y
-56.44%
RETURN ON ASSETS (ROA) AVG 10Y
-88.10%
RETURN ON ASSETS (ROA) AVG 15Y
-83.14%
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
-0.88%
CURRENT VS 3Y AVG
-0.97%
CURRENT VS 5Y AVG
-11.33%
CURRENT VS 10Y AVG
+28.67%
CURRENT VS 15Y AVG
+24.42%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-32.27%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
-94.76%
vs the sector median at left
Tonix Pharmaceuticals Holding Corp.
Market Cap
$122.66M
Return on Assets (ROA)
-62.84%
TTM Avg
-62.29%
3Y Avg
-62.24%
5Y Avg
-56.44%
Market Cap
$122.43M
Return on Assets (ROA)
-4.60%
TTM Avg
-3.66%
3Y Avg
-5.21%
5Y Avg
-1.02%
Market Cap
$124.18M
Return on Assets (ROA)
-96.49%
TTM Avg
-109.25%
3Y Avg
-126.41%
5Y Avg
-190.40%
Market Cap
$124.70M
Return on Assets (ROA)
-87.44%
TTM Avg
-86.57%
3Y Avg
-87.06%
5Y Avg
-85.09%
Market Cap
$120.58M
Return on Assets (ROA)
-1.70%
TTM Avg
-35.34%
3Y Avg
-51.03%
5Y Avg
-36.99%
Market Cap
$120.41M
Return on Assets (ROA)
-26.48%
TTM Avg
-24.24%
3Y Avg
-21.83%
5Y Avg
-17.99%
Market Cap
$119.84M
Return on Assets (ROA)
-31.33%
TTM Avg
-56.73%
3Y Avg
-59.49%
5Y Avg
-64.55%
Market Cap
$118.83M
Return on Assets (ROA)
-53.26%
TTM Avg
-24.98%
3Y Avg
-43.10%
5Y Avg
-143.56%
Market Cap
$118.59M
Return on Assets (ROA)
-110.24%
TTM Avg
-77.16%
3Y Avg
-67.85%
5Y Avg
-53.38%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Tonix Pharmaceuticals Holding Corp. (TNXP) | $122.66M | -62.84% | -62.29% | -62.24% | -56.44% |
| BGM Group Ltd. (BGM)vs › | $122.43M | -4.60% | -3.66% | -5.21% | -1.02% |
| TuHURA Biosciences, Inc. (HURA)vs › | $124.18M | -96.49% | -109.25% | -126.41% | -190.40% |
| Entera Bio Ltd. (ENTX)vs › | $124.70M | -87.44% | -86.57% | -87.06% | -85.09% |
| enGene Holdings Inc. (ENGN)vs › | $120.58M | -1.70% | -35.34% | -51.03% | -36.99% |
| Seer, Inc. (SEER)vs › | $120.41M | -26.48% | -24.24% | -21.83% | -17.99% |
| Cibus, Inc. (CBUS)vs › | $119.84M | -31.33% | -56.73% | -59.49% | -64.55% |
| LENZ Therapeutics, Inc. (LENZ)vs › | $118.83M | -53.26% | -24.98% | -43.10% | -143.56% |
| Tenaya Therapeutics, Inc. (TNYA)vs › | $118.59M | -110.24% | -77.16% | -67.85% | -53.38% |
| NRx Pharmaceuticals, Inc. (NRXP)vs › | $127.29M | -68.74% | -454.56% | -368.82% | -586.69% |
ROA
-62.8%
ROE
-71.8%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -44.75% |
| 2024-12-31 | -79.83% |
| 2023-12-31 | -75.53% |
| 2022-12-31 | -48.84% |
| 2021-12-31 | -38.31% |
| 2020-12-31 | -51.40% |
| 2019-12-31 | -196.58% |
| 2018-12-31 | -111.54% |
| 2017-12-31 | -78.95% |
| 2016-12-31 | -141.19% |
| 2015-12-31 | -102.20% |
| 2014-12-31 | -69.84% |
| 2013-12-31 | -124.59% |
| 2012-12-31 | -0.45% |
| 2011-12-31 | -815.64% |
| 2010-12-31 | -383.30% |
| 2009-12-31 | -236.87% |
| 2008-12-31 | -46.03% |
